Generic drugs and biosimilars get last-minute reprieve from rebates with Senate tweaks to Build Back Better Act

The Senate Finance Committee on Saturday released the latest text of President Joe Biden’s $2 trillion spending package, paid for at least in part with new negotiating power for Medicare and inflation rebates drugmakers will have to pay if their drug prices rise too quickly each year.